News

Each month Dean Mary E. Klotman offers her thoughts and ideas about important and timely topics and issues related to medical education,
science and discovery, and patient care.

In a recently published  Journal of Academic Ophthalmology article

Duke Eye Center’s Basic Science Research Led to Development of the First New Glaucoma Drug to be FDA-Approved in 20 Years

Starting with the approval of rituximab in 1997, molecularly targeted cancer drugs have transformed the way cancer treatment is approached. However, the new drugs are not without risks.

Cynthia Toth, MD was awarded the Paul Henkind Memorial Lecture for the 41st Annual Macula Society Meeting held February 21-24, 2018.

We are pleased to announce that Felipe Medeiros, MD, PhD has been named the Director and Eleonora Lad, MD, PhD has been named the Associate Director for Duke Ophthalmology's Clinical Research Unit

Low Luminance Questionnaire (LLQ) scores were significantly associated with computerized low luminance visual acuity (LLVA) and low luminance deficit (LLD) in patients with early/intermediate age-r

VISION is our annual publication that details our accomplishments, achievements and advancements in the clinic and the lab over the last year. 

Highlights from this issue include:

This month RetinaLink is pleased to feature Lejla Vajzovic, MD

Jullia Rosdahl, MD, PhD has been named the new Director for Medical Student Education effective July 1, 2018.